1. Home
  2. LEE vs RVPH Comparison

LEE vs RVPH Comparison

Compare LEE & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • RVPH
  • Stock Information
  • Founded
  • LEE 1890
  • RVPH 2006
  • Country
  • LEE United States
  • RVPH United States
  • Employees
  • LEE N/A
  • RVPH N/A
  • Industry
  • LEE Newspapers/Magazines
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEE Consumer Discretionary
  • RVPH Health Care
  • Exchange
  • LEE Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • LEE 90.6M
  • RVPH 88.0M
  • IPO Year
  • LEE N/A
  • RVPH N/A
  • Fundamental
  • Price
  • LEE $11.46
  • RVPH $1.80
  • Analyst Decision
  • LEE
  • RVPH Strong Buy
  • Analyst Count
  • LEE 0
  • RVPH 5
  • Target Price
  • LEE N/A
  • RVPH $11.40
  • AVG Volume (30 Days)
  • LEE 23.4K
  • RVPH 1.6M
  • Earning Date
  • LEE 02-06-2025
  • RVPH 11-14-2024
  • Dividend Yield
  • LEE N/A
  • RVPH N/A
  • EPS Growth
  • LEE N/A
  • RVPH N/A
  • EPS
  • LEE N/A
  • RVPH N/A
  • Revenue
  • LEE $600,264,000.00
  • RVPH N/A
  • Revenue This Year
  • LEE N/A
  • RVPH N/A
  • Revenue Next Year
  • LEE N/A
  • RVPH N/A
  • P/E Ratio
  • LEE N/A
  • RVPH N/A
  • Revenue Growth
  • LEE N/A
  • RVPH N/A
  • 52 Week Low
  • LEE $7.57
  • RVPH $0.60
  • 52 Week High
  • LEE $19.63
  • RVPH $4.50
  • Technical
  • Relative Strength Index (RSI)
  • LEE 32.32
  • RVPH 45.36
  • Support Level
  • LEE $11.40
  • RVPH $1.97
  • Resistance Level
  • LEE $13.69
  • RVPH $2.14
  • Average True Range (ATR)
  • LEE 0.80
  • RVPH 0.16
  • MACD
  • LEE -0.10
  • RVPH -0.02
  • Stochastic Oscillator
  • LEE 6.58
  • RVPH 29.29

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: